查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1800820

2025 年至 2033 年生物資訊市場報告（按產品和服務、應用、最終用途部門和地區分類）

Bioinformatics Market Report by Product and Service, Application, End-Use Sector, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球生物資訊市場規模達139億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到394億美元，2025-2033年期間的複合年成長率（CAGR）為11.69%。科技的快速進步、基因組定序的不斷成長、個人化醫療需求的激增、資料分析的成長、研發投入的不斷增加、生物資料庫的不斷擴展以及對預防保健的日益關注，都是推動市場成長的一些因素。

生物資訊市場分析：

  • 市場成長與規模：生物資訊市場正經歷大幅成長，這得益於其在醫療保健、農業和環境生物技術領域的關鍵作用。市場規模的不斷擴大體現了這一擴張，預測顯示其呈現強勁的上升趨勢。這種成長的動力源於對整合資料解決方案日益成長的需求、生物資料量的激增以及生物資訊學在各個科學領域的廣泛應用。正如生物資訊市場研究所強調的那樣，該領域在解讀複雜的生物資料集、推動個人化醫療創新以及增進我們對疾病遺傳和分子基礎的理解方面正變得不可或缺，從而為市場的擴張和發展做出了重大貢獻。
  • 主要市場促進因素：主要的市場促進因素包括：由於成本效益高，對核酸和蛋白質定序的需求不斷成長；雲端運算的整合；以及微生物基因組計畫的興起。此外，對資料整合和管理的日益重視；臨床診斷和精準醫療的廣泛應用；生物製藥行業的擴張；以及分子生物學的進步；對免疫基因組學的日益關注，這些因素正在推動市場成長。此外，對生物資訊學新創企業的投資增加；以及結合計算和生物學研究的合作項目的激增，共同推動了生物資訊學市場的成長，塑造了一個充滿活力且快速發展的格局。
  • 技術進步：技術進步仍然是生物資訊市場的關鍵力量，持續創新是解決生物資料複雜性的關鍵。增強的運算能力、複雜的演算法和機器學習 (ML) 應用有助於推動基因組學和蛋白​​質組學分析的發展。這些技術進步不僅擴展了生物資訊學工具的功能，也拓寬了其在醫療保健、農業和環境研究等不同領域的適用性。這些進步確保了生物資訊學領域始終處於科學研究的前沿，促進了生物資料的快速、準確和經濟高效的分析，這對於生物資訊市場趨勢至關重要。
  • 產業應用：生物資訊學的產業應用涵蓋醫療保健、製藥、農業和環境科學領域。在醫療保健領域，它對於開發個人化醫療和了解遺傳疾病至關重要。製藥業依賴生物資訊學進行藥物發現、開發和生物標記識別。在農業領域，它有助於作物改良和牲畜管理；而在環境科學領域，它用於生物多樣性保護和生態系統健康監測。
  • 主要市場趨勢：生物資訊市場的特點是人工智慧 (AI) 和機器學習 (ML) 在資料分析中的應用日益增多，個人化醫療對基因組資料解讀的需求日益成長，在臨床診斷中的應用日益廣泛，以及基於雲端的生物資訊解決方案的不斷擴展。此外，對利用基因組資料的精準農業的重視、對生物標記發現需求的激增以及多組學資料整合用於綜合分析的需求，正在推動市場成長。
  • 地理趨勢：生物資訊市場呈現出顯著的地理差異，北美憑藉其先進的技術基礎設施、雄厚的研發投入以及關鍵產業參與者的強大影響力而處於領先地位。該地區的主導地位歸功於其對新一代定序和高通量計算的快速應用，以及生物資訊學在醫療保健和農業生物技術領域的廣泛應用。歐洲和亞太地區也是顯著的貢獻者，其中歐洲受益於其強大的研究框架，而亞太地區則由於生物技術企業的興起和政府支持的不斷增加而實現了快速成長。
  • 競爭格局：生物資訊市場的競爭格局瞬息萬變，既有成熟企業，也有新興新創企業。這些企業在創新、技術實力和策略合作方面展開競爭。市場領導者不斷投資研發，推出先進的解決方案，以因應日益複雜的生物資料分析。隨著企業努力提升產品服務並擴大市場覆蓋範圍，該產業也呈現併購趨勢。
  • 挑戰與機會：生物資訊市場充滿挑戰，包括資料複雜性、對專業技能的需求以及與資料隱私和安全相關的問題。然而，這些挑戰也為市場成長和創新帶來了獨特的機會。生物資料量的不斷成長催生了更複雜的生物資訊學工具的開發，這為人工智慧和機器學習的進步創造了機會。此外，個人化醫療需求的不斷成長以及生物資訊學在各行各業的廣泛應用，也為該行業帶來了廣闊的前景。

生物資訊市場趨勢：

技術進步

技術進步是生物資訊市場發展的基石，深刻影響其發展和能力。計算演算法、高通量測序技術和增強型資料處理軟體的創新徹底改變了生物資訊學，使海量生物資料集的分析速度和精度達到前所未有的水平。這些進步促進了複雜的基因組學和蛋白​​質組學分析，從而在理解生物過程和疾病機制方面取得了重大突破。它們也推動了更複雜的生物資訊學工具的開發，提高了基因組學、轉錄組學和其他各種組學領域的研究效率，從而加速了科學發現及其在個人化醫療、藥物研發和其他領域的應用。

增加基因組定序

基因組定序的激增是關鍵驅動力，其推動力源自於定序技術成本的下降和可近性的提高。隨著測序的日益普及，它會產生大量資料，因此需要先進的生物資訊工具來有效地儲存、管理和分析資料。基因組資料的這種指數級成長對於推進個人化醫療、了解疾病的遺傳易感性以及開發標靶療法至關重要。快速且經濟地進行基因組定序的能力已經徹底改變了生物學研究，使得人類遺傳學、進化生物學和微生物基因組學的研究更加全面，從而突破了生物資訊學的界限，使其能夠管理和解讀這些海量資料集的複雜性。

個人化醫療需求激增

個人化醫療的需求正在顯著塑造生物資訊學市場，強調醫療保健的個人化，即根據個別患者量身定做醫療決策和治療方案。這種方法利用基因組和臨床資料來了解疾病的分子基礎，預測特定疾病的易感性，並設計個人化治療方案。生物資訊學是這個過程不可或缺的一部分，它提供強大的計算能力來分析和解讀影響健康和疾病的基因變異和分子模式。由此產生的洞察使醫療保健提供者能夠做出更明智的決策，提供有針對性的治療方案，並改善患者的治療效果，從而推動了臨床領域對複雜生物資訊解決方案的需求。

數據分析成長

生物資訊學中資料分析的發展具有變革性，它提供了強大的工具來解讀基因組定序、基因表現研究和其他組學技術產生的複雜資料。生物資訊學越來越注重整合基因組學、轉錄組學、蛋白質組學和代謝組學等多個組學層面的資料，從而更全面地理解生物系統和疾病機制。此外，生物資訊學中的資料分析在很大程度上依賴機器學習 (ML) 和人工智慧 (AI) 技術進行預測建模、模式識別和資料解讀。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球生物資訊市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品與服務

  • 知識管理工具
    • 主要類型
      • 通用知識管理工具
      • 專業的知識管理工具
  • 生物資訊平台
    • 主要類型
      • 手術模擬平台
      • 序列分析、比對和操作平台
      • 結構和功能分析平台
      • 其他
  • 生物資訊服務
    • 主要類型
      • 數據分析服務
      • 資料庫管理服務
      • 其他

第7章：市場區隔：依應用

  • 基因組學
  • 化學資訊學與藥物設計
  • 蛋白質體學
  • 轉錄組學
  • 代謝組學
  • 其他應用

第8章：市場區隔：依最終用途領域

  • 醫學生物技術
  • 學者
  • 動物生物技術
  • 農業生物技術
  • 環境生物技術
  • 法醫生物技術
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：SWOT分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • ABM Industries
    • Agilent Technologies
    • Biomax Informatics
    • Data4cure Inc.
    • Dnastar Inc.
    • Illumina Inc.
    • Life Technologies
    • Perkinelmer Inc.
    • Qiagen NV
    • Quest Diagnostics
    • Sophia Genetics SA
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
    • WuXi Nextcode Genomics
Product Code: SR112025A2129

The global bioinformatics market size reached USD 13.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.4 Billion by 2033, exhibiting a growth rate (CAGR) of 11.69% during 2025-2033. Rapid technological advancements, increasing genomic sequencing, surging demand for personalized medicine, data analytics growth, investment in research and development (R&D), expanding biological databases, and the rising focus on preventive care are some of the factors fostering the market growth.

Bioinformatics Market Analysis:

  • Market Growth and Size: The bioinformatics market is witnessing substantial growth, propelled by its critical role in healthcare, agriculture, and environmental biotechnology. The expansion is reflected in the increasing market size, with projections indicating robust upward trends. This growth is fueled by the escalating demand for integrated data solutions, the burgeoning volume of biological data, and the widespread application of bioinformatics in various scientific domains. As bioinformatics market research underscores, this sector is becoming indispensable in deciphering complex biological datasets, driving innovations in personalized medicine, and enhancing our understanding of genetic and molecular foundations of diseases, thereby contributing significantly to the market's expansion and evolution.
  • Major Market Drivers: The major market drivers include the escalating demand for nucleic acid and protein sequencing due to its cost-effectiveness, the integration of cloud computing, and the rise in microbial genome projects. Moreover, the increasing emphasis on data integration and management, widespread utilization in clinical diagnostics and precision medicine, expansion in the biopharmaceutical industry, and advancements in molecular biology, rising focus on immunogenomics, which is boosting the market growth. Apart from this, enhanced investment in bioinformatics startups and the surge in collaborative projects combining computational and biological research, collectively fuel the bioinformatics market growth, shaping a dynamic and rapidly evolving landscape.
  • Technological Advancements: Technological advancements remain a pivotal force in the bioinformatics market, where ongoing innovation is key to addressing the complexity of biological data. Enhanced computational power, sophisticated algorithms, and machine learning (ML) applications are instrumental in advancing genomic and proteomic analyses. These technological strides are not only expanding the capabilities of bioinformatics tools but also are broadening their applicability across different sectors, including healthcare, agriculture, and environmental studies. Such advancements ensure that the bioinformatics field stays at the forefront of scientific research, facilitating rapid, accurate, and cost-effective analysis of biological data, which is essential for bioinformatics market trends.
  • Industry Applications: The industry applications of bioinformatics span across healthcare, pharmaceuticals, agriculture, and environmental sciences. In healthcare, it's pivotal for developing personalized medicine and understanding genetic disorders. The pharmaceutical sector relies on bioinformatics for drug discovery, development, and biomarker identification. In agriculture, it aids in crop improvement and livestock management, while in environmental science, it's used for biodiversity conservation and monitoring ecosystem health.
  • Key Market Trends: The bioinformatics market is characterized by the increasing use of artificial intelligence (AI) and ML in data analysis, the rise of personalized medicine requiring genomic data interpretation, the growing application in clinical diagnostics, and the expansion of cloud-based bioinformatics solutions. Moreover, the emphasis on precision agriculture leveraging genomic data, the surge in demand for biomarker discovery, and the integration of multi-omics data for comprehensive analysis are boosting the market growth.
  • Geographical Trends: The bioinformatics market exhibits significant geographical disparities, with North America leading due to its advanced technological infrastructure, substantial investments in R&D, and strong presence of key industry players. The region's dominance is attributed to its rapid adoption of next-generation sequencing, high-throughput computing, and extensive use of bioinformatics in healthcare and agricultural biotechnology. Europe and Asia-Pacific are also notable contributors, with Europe benefiting from its robust research framework and Asia-Pacific witnessing fast-paced growth due to rising biotechnology ventures and increasing governmental support.
  • Competitive Landscape: The competitive landscape of the bioinformatics market is intensely dynamic, featuring a mix of established companies and emerging startups. These entities compete on innovation, technological prowess, and strategic collaborations. Market leaders are continuously investing in R&D to introduce advanced solutions that cater to the growing complexity of biological data analysis. The sector is also witnessing a trend of mergers and acquisitions, as companies strive to enhance their offerings and expand their market reach.
  • Challenges and Opportunities: The bioinformatics market is laden with challenges, including data complexity, the need for specialized skills, and issues related to data privacy and security. However, these challenges present unique opportunities for market growth and innovation. The increasing volume of biological data necessitates the development of more sophisticated bioinformatics tools, creating opportunities for advancements in AI and machine learning. Moreover, the growing demand for personalized medicine and the expanding application of bioinformatics across various industries offer vast prospects for the sector.

Bioinformatics Market Trends:

Technological advancements

Technological advancements are a cornerstone driver of the bioinformatics market, profoundly impacting its growth and capabilities. Innovations in computational algorithms, high-throughput sequencing technologies, and enhanced data processing software have revolutionized bioinformatics, enabling the analysis of vast biological datasets at unprecedented speeds and accuracy. These advancements facilitate complex genomic and proteomic analyses, leading to significant breakthroughs in understanding biological processes and disease mechanisms. They also enable the development of more sophisticated bioinformatics tools, improving the efficiency of research in genomics, transcriptomics, and various other omics fields, thereby accelerating scientific discoveries and their applications in personalized medicine, drug discovery, and other areas.

Increased genomic sequencing

The surge in genomic sequencing is a pivotal driver, fueled by the declining costs and improved accessibility of sequencing technologies. As sequencing becomes more widespread, it generates enormous volumes of data, necessitating advanced bioinformatics tools for effective data storage, management, and analysis. This exponential increase in genomic data is crucial for advancing personalized medicine, understanding genetic predispositions to diseases, and developing targeted therapies. The ability to sequence genomes rapidly and affordably has transformed biological research, enabling more comprehensive studies of human genetics, evolutionary biology, and microbial genomics, thus pushing the boundaries of bioinformatics to manage and decipher the complexity of these vast datasets.

Surging demand for personalized medicine

The demand for personalized medicine is significantly shaping the bioinformatics market, emphasizing the customization of healthcare, with medical decisions and treatments tailored to individual patients. This approach leverages genomic and clinical data to understand the molecular basis of diseases, predict the susceptibility to specific illnesses, and design personalized treatment regimens. Bioinformatics is integral to this process, providing the computational power to analyze and interpret the genetic variations and molecular patterns that influence health and disease. The resulting insights enable healthcare providers to make more informed decisions, offer targeted therapies, and improve patient outcomes, thereby driving the demand for sophisticated bioinformatics solutions in clinical settings.

Data analytics growth

The growth of data analytics in bioinformatics is transformative, offering powerful tools to decipher the complex data generated by genomic sequencing, gene expression studies, and other omic technologies. Bioinformatics is increasingly focusing on integrating data from multiple omics levels such as genomics, transcriptomics, proteomics, and metabolomics that provides a more comprehensive understanding of biological systems and disease mechanisms. Moreover, data analytics in bioinformatics heavily relies on machine learning (ML) and artificial intelligence (AI) techniques for predictive modeling, pattern recognition, and data interpretation.

Bioinformatics Industry Segmentation:

Breakup by Product and Service:

  • Knowledge Management Tools
    • Generalized Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Bioinformatics Platforms
    • Surgical Simulation Platforms
    • Sequence Analysis, Alignment and Manipulation Platforms
    • Structural and Functional Analysis Platforms
    • Others
  • Bioinformatics Services
    • Data Analysis Services
    • Database Management Services
    • Others

Bioinformatics platforms dominates the market

The bioinformatics platforms segment is driven by the increasing complexity and volume of biological data, necessitating advanced platforms for data analysis, integration, and interpretation. The surge in genomic and proteomic studies, the expanding applications of next-generation sequencing, and the growing demand for integrative platforms for multidisciplinary research are key factors. These platforms are essential for translating vast biological data sets into comprehensible insights, facilitating advancements in personalized medicine, drug discovery, and genetic research.

The knowledge management tools segment is driven by the increasing need for organizations to harness the vast amounts of data generated and to transform this data into actionable insights. Factors such as the growing emphasis on decision-making based on data-driven insights, the escalating need for market intelligence, and the rising importance of enhancing operational efficiency are pivotal. Organizations are adopting these tools to improve innovation, streamline operations, and maintain competitive advantages by effectively managing, retrieving, and utilizing knowledge.

The bioinformatics services segment is driven by the increasing outsourcing of bioinformatics projects, the need for specialized expertise, and the growing demand for cost-effective and efficient data analysis solutions. Pharmaceutical and biotechnology companies, along with academic and research institutions, are leveraging these services to cope with the complexity of bioinformatics analyses, focus on core competencies, and accelerate the pace of research and development. The services segment is crucial for providing tailored solutions that address specific research requirements, ensuring high-quality analysis and interpretation of biological data.

Breakup by Application:

  • Genomics
  • Chemoinformatics and Drug Design
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Others

Genomics accounts for the majority of the market share

The genomics segment is driven by the increasing affordability of sequencing technologies, advancements in high-throughput sequencing methods, and a growing emphasis on personalized medicine. The expanding applications of genomics in understanding genetic variations, disease mechanisms, and therapeutic targets are catalyzing its adoption across various fields, including healthcare, agriculture, and biotechnology. This segment benefits significantly from continuous innovations in sequencing technologies, bioinformatics tools, and the integration of genomics with other omics disciplines, enhancing its impact on precision medicine, genetic research, and evolutionary biology.

The chemoinformatics and drug design segment is driven by the increasing demand for new therapeutic agents, the need for cost-effective drug development processes, and the integration of artificial intelligence and machine learning technologies. This segment leverages computational tools to understand drug-receptor interactions, predict pharmacokinetic and toxicological properties, and streamline the drug discovery pipeline. The growth of this segment is further propelled by the pharmaceutical industry's shift towards data-driven methodologies, the expansion of chemical databases, and the advancement of simulation and modeling techniques, all of which enhance the efficiency and effectiveness of drug discovery and development.

The proteomics segment is driven by the increasing advancements in mass spectrometry technologies, the growing demand for personalized medicine, and the expanding applications of proteomics in biomarker discovery and disease diagnostics. This segment benefits from the integration of proteomics data with other omics data, which enhances the understanding of cellular processes and disease mechanisms. The continuous improvement in proteomic workflows, the development of high-throughput and sensitive analytical techniques, and the increasing focus on systems biology are key factors contributing to the growth of this segment, enabling deeper insights into protein function, structure, and interactions.

The transcriptomics segment is driven by the increasing adoption of RNA sequencing technologies, the growing interest in understanding gene expression patterns, and the expanding application of transcriptomics in disease research and drug discovery. This segment is benefiting from advancements in sequencing technologies, computational biology, and the integration of transcriptomic data with genomics and proteomics, which enriches the understanding of gene regulation, cellular responses, and molecular mechanisms underlying various conditions.

The metabolomics segment is driven by the increasing application of metabolomics in clinical diagnostics, the growing emphasis on understanding metabolic pathways, and the advancements in analytical techniques like mass spectrometry. This segment is crucial for elucidating the functional state of biological systems, providing insights into the phenotypic changes caused by genetic or environmental factors. The integration of metabolomics with other omics technologies, the growing demand for biomarker discovery, and the expanding applications in personalized medicine and nutritional research are key factors propelling the growth of this segment, offering comprehensive insights into the metabolic processes and their implications in health and disease.

The others segment in bioinformatics is driven by the increasing demand for integrated omics approaches, the expansion of applications in areas such as epigenomics, pharmacogenomics, and environmental genomics, and the growing need for advanced computational tools to analyze complex datasets. This segment encompasses a variety of specialized fields that leverage bioinformatics technologies to explore the biological data beyond conventional omics studies.

Breakup by End-Use Sector:

  • Medical Biotechnology
  • Academics
  • Animal Biotechnology
  • Agricultural Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Others

Medical biotechnology accounts for the majority of the market share

The medical biotechnology segment is driven by the increasing demand for personalized medicine, advancements in genetic engineering, and the growing prevalence of chronic diseases. Innovations in gene therapy, stem cell technology, and regenerative medicine are revolutionizing treatments, making them more effective and tailored to individual genetic profiles. The surge in biopharmaceuticals, including vaccines and therapeutic proteins, and the emphasis on early disease detection and prevention are key factors propelling this segment forward. These developments are enhancing patient outcomes, reducing healthcare costs, and leading to the discovery of novel therapeutics, thereby fueling the growth of medical biotechnology.

The academics segment is driven by the increasing collaboration between research institutions and the biotechnology industry, the growing focus on genomic and proteomic research, and the rising demand for biotechnology education. Enhanced funding for research projects, the integration of advanced technologies in academic curricula, and the emphasis on developing innovative biotechnological applications are pivotal.

The animal biotechnology segment is driven by the increasing investment in veterinary research, the demand for enhanced animal health and productivity, and the development of genetically modified animals. Breakthroughs in animal genetics, vaccine development, and reproductive technologies are instrumental in improving animal breeding, disease resistance, and protein production. This segment's growth is further supported by the ethical production of transgenic animals, advancements in cloning and stem cell research, and the application of biotechnological methods in wildlife conservation, thus offering significant contributions to veterinary medicine and livestock management.

The agricultural biotechnology segment is driven by the increasing global demand for food, the need for pest and disease resistance, and the urgency to adapt to climate change. Genetic modifications in crops for improved yield, quality, and nutritional value, along with advancements in biopesticides and biofertilizers, are crucial developments. This segment leverages biotechnological tools for sustainable farming practices, enhancing crop resilience to environmental stresses, and reducing agricultural inputs, which are vital for food security and agricultural sustainability, thus playing a key role in the global agricultural landscape.

The environmental biotechnology segment is driven by the increasing need for waste management, pollution reduction, and sustainable environmental practices. The application of microbial systems for bioremediation, the development of bioenergy sources, and the use of biotechnological processes for water treatment are pivotal. This segment focuses on harnessing biological systems for the detoxification of contaminated environments, the recycling of waste materials, and the production of green energy, thereby contributing significantly to environmental sustainability and the conservation of natural resources.

The forensic biotechnology segment is driven by the increasing demand for accurate and speedy forensic investigations and advancements in molecular diagnostics. The application of biotechnological tools in crime scene analysis, the development of sophisticated forensic databases, and the enhancement of legal frameworks are key factors. This segment benefits from the precision and reliability of biotechnological methods in forensic science, providing crucial evidence in criminal cases, identifying victims of disasters, and contributing to the justice system, thereby playing a vital role in law enforcement and forensic investigations.

The others segment, which includes industrial, marine, and food biotechnology, is driven by the diverse applications of biotechnological processes in various sectors. The development of bio-based chemicals, the use of enzymes in industrial processes, and the advancement of marine biotechnology for new drug discovery are key factors.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest Bioinformatics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others);Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America bioinformatics market is driven by the increasing investment in biotechnology and pharmaceutical research, the presence of a robust technological infrastructure, and significant governmental and private funding for genomics research. The region benefits from a well-established healthcare system, a high rate of adoption of advanced technologies, and the presence of leading bioinformatics companies, which collectively fuel innovation and market expansion.

The Europe bioinformatics market is driven by the increasing focus on precision medicine, strong governmental support for research in genomics, and collaborations between academia and the biotech industry. The region's advanced healthcare infrastructure, coupled with high healthcare expenditure, facilitates the adoption of bioinformatics tools, supporting the market's growth and the development of new applications.

The Asia Pacific bioinformatics market is driven by the rapidly growing biotechnology sector, increasing government initiatives in genomics research, and rising investments in healthcare technology. The region's growing emphasis on personalized medicine and the expansion of the pharmaceutical and agriculture sectors contribute significantly to the adoption of bioinformatics, making it a fast-evolving market.

The Latin America bioinformatics market is driven by the increasing healthcare expenditure, growing biotech and pharmaceutical sectors, and rising awareness about the potential of genomics research. Although in the nascent stage, the market benefits from the gradual adoption of advanced technologies and the improving healthcare infrastructure, which are pivotal for the region's bioinformatics advancements.

The Middle East and Africa bioinformatics market is driven by the growing demand for personalized healthcare, increasing investment in healthcare infrastructure, and the rising prevalence of genetic disorders. The market is also benefiting from the expanding research in genomics and the increasing collaboration between regional and international research institutions, fostering a gradual yet promising growth in the bioinformatics landscape.

Leading Key Players in the Bioinformatics Industry:

In the bioinformatics market, key players are actively engaged in a range of strategic activities to bolster their market position and respond to the rapidly evolving technological landscape. They are heavily investing in research and development (R&D) to innovate and enhance bioinformatics tools, software, and services, ensuring they can handle the increasing complexity and volume of biological data. Collaborations and partnerships are a cornerstone strategy, as companies join forces with academic institutions, research labs, and other firms to combine expertise, share resources, and co-develop advanced solutions that cater to the specific needs of the scientific community. Additionally, these players are focusing on expanding their product portfolios through mergers and acquisitions, enabling them to offer more comprehensive solutions and gain a competitive edge. They are also intensifying their efforts in customer training and support, ensuring users can maximize the benefits of their bioinformatics solutions, thereby driving market growth and innovation.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • ABM Industries
  • Agilent Technologies
  • Biomax Informatics
  • Data4Cure Inc.
  • Dnastar Inc.
  • Illumina Inc.
  • Life Technologies
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • Sophia Genetics SA
  • Thermo Fisher Scientific Inc.
  • Waters Corp
  • WuXi Nextcode Genomics

Key Questions Answered in This Report

  • 1.What is the global bioinformatics market growth?
  • 2.What are the global bioinformatics market drivers?
  • 3.What are the key industry trends in the global bioinformatics market?
  • 4.What is the impact of COVID-19 on the global bioinformatics market?
  • 5.What is the global bioinformatics market breakup by product and service?
  • 6.What are the major regions in the global bioinformatics market?
  • 7.Who are the key companies/players in the global bioinformatics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bioinformatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Knowledge Management Tools
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Generalized Knowledge Management Tools
      • 6.1.2.2 Specialized Knowledge Management Tools
    • 6.1.3 Market Forecast
  • 6.2 Bioinformatics Platforms
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Surgical Simulation Platforms
      • 6.2.2.2 Sequence Analysis, Alignment and Manipulation Platforms
      • 6.2.2.3 Structural and Functional Analysis Platforms
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Bioinformatics Services
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Data Analysis Services
      • 6.3.2.2 Database Management Services
      • 6.3.2.3 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chemoinformatics and Drug Design
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Proteomics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Transcriptomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Metabolomics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Other Applications
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-Use Sector

  • 8.1 Medical Biotechnology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Animal Biotechnology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Agricultural Biotechnology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Environmental Biotechnology
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Forensic Biotechnology
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 ABM Industries
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Agilent Technologies
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Biomax Informatics
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Data4cure Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Dnastar Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Illumina Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Life Technologies
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Qiagen N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Quest Diagnostics
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sophia Genetics SA
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Waters Corporation
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
      • 13.3.13.4 SWOT Analysis
    • 13.3.14 WuXi Nextcode Genomics
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio

List of Figures

  • Figure 1: Global: Bioinformatics Market: Major Drivers and Challenges
  • Figure 2: Global: Bioinformatics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bioinformatics Market: Breakup by Product and Service (in %), 2024
  • Figure 4: Global: Bioinformatics Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Bioinformatics Market: Breakup by End-Use Sector (in %), 2024
  • Figure 6: Global: Bioinformatics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Bioinformatics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Bioinformatics (Knowledge Management Tools) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Bioinformatics (Knowledge Management Tools) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Bioinformatics (Bioinformatics Platforms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Bioinformatics (Bioinformatics Platforms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Bioinformatics (Bioinformatics Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Bioinformatics (Bioinformatics Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Bioinformatics (Genomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Bioinformatics (Genomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Bioinformatics (Chemoinformatics and Drug Design) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Bioinformatics (Chemoinformatics and Drug Design) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Bioinformatics (Proteomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Bioinformatics (Proteomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Bioinformatics (Transcriptomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Bioinformatics (Transcriptomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Bioinformatics (Metabolomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Bioinformatics (Metabolomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Bioinformatics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Bioinformatics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Bioinformatics (Medical Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Bioinformatics (Medical Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Bioinformatics (Academics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Bioinformatics (Academics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Bioinformatics (Animal Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Bioinformatics (Animal Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Bioinformatics (Agricultural Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Bioinformatics (Agricultural Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Bioinformatics (Environmental Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Bioinformatics (Environmental Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Bioinformatics (Forensic Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Bioinformatics (Forensic Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Bioinformatics (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Bioinformatics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia Pacific: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia Pacific: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Bioinformatics Industry: SWOT Analysis
  • Figure 89: Global: Bioinformatics Industry: Value Chain Analysis
  • Figure 90: Global: Bioinformatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bioinformatics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Bioinformatics Market Forecast: Breakup by Product and Service (in Million USD), 2025-2033
  • Table 3: Global: Bioinformatics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Bioinformatics Market Forecast: Breakup by End-Use Sector (in Million USD), 2025-2033
  • Table 5: Global: Bioinformatics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Bioinformatics Market: Competitive Structure
  • Table 7: Global: Bioinformatics Market: Key Players